Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Postoperative Delirium in Older Laparoscopic Colorectal Cancer Surgery Patients
ChiCTR2300076990Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in colorectal cancer (CRC) (2 arms), sponsored by Dazhou Central Hospital. Primary endpoints: Incidence of postoperative delirium within 3 days after surgery and Cognitive function status. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2300076990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076990.